3.52Open3.52Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover231.44%IV6.17%PremiumJan 17, 2025Expiry Date2.88Intrinsic Value100Multiplier11DDays to Expiry0.64Extrinsic Value100Contract SizeAmericanOptions Type0.8412Delta0.0567Gamma3.12Leverage Ratio-0.0459Theta0.0017Rho2.63Eff Leverage0.0045Vega
KKR Real Estate Finance Trust Stock Discussion
• $Okta (OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo (STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics (TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals (AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
No comment yet